Ticker

President's Budget requested significant FDA funding increases, signaling growing support for Else's next-generation plant-based infant formula Builds Upon FY26 Congressional Appropriations Directive Report Language to Implement and Modernize Guidance for Plant-Based, Non-Soy, Non-Dairy Infant Formulas VANCOUVER, BC, April 15, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL)…

/PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), today reported financial results for the 2025

Else Nutrn (OTCMKTS:BABYF - Get Free Report) and Medtronic (NYSE: MDT - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations. Earnings and Valuation This table compares Else Nutrn and

Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential VANCOUVER, BC, March 10, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) ("Else" or the "Company"), a pioneer in whole-food plant-based, non-soy, non-dairy nutrition for early childhood nutrition, today announced that the U.S. Food and…

Milestone underscores accelerating consumer demand for clean, dairy-free nutrition alternatives    VANCOUVER, BC, Jan. 29, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTC: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), a pioneer in whole-food plant-based, non-soy, non-dairy nutrition for early childhood nutrition, proudly announces it has surpassed one million total cans sold across its toddler and…